Viewing Study NCT06908733


Ignite Creation Date: 2025-12-25 @ 2:41 AM
Ignite Modification Date: 2025-12-28 @ 8:24 PM
Study NCT ID: NCT06908733
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-04-03
First Post: 2025-03-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Integrating Surgery and Radiotherapy Following Tislelizumab-based Conversion Therapy in N3-Stage III NSCLC
Sponsor: Liaoning Cancer Hospital & Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module